Condition · ICD-10 G35

Multiple Sclerosis

MS

An autoimmune disease in which the immune system attacks the protective myelin sheath covering nerve fibers.

Multiple sclerosis is a chronic neurological condition causing demyelination of the central nervous system. It leads to a wide range of symptoms including fatigue, vision problems, and mobility issues. Disease-modifying therapies aim to reduce relapse frequency and slow progression.

At a glance
Medications tracked
8
First-line options
Ocrelizumab, Interferon beta-1a, Peginterferon beta-1a
Related conditions
Neuromyelitis OpticaLupusMyasthenia GravisFibromyalgia

First-line Related Treatments

Commonly associated primary options — verify with your clinician

Primary options
Ocrelizumab
Ocrelizumab
Rx
Injection
Strength 300 mg/10mL
NDC 50242-0150-01
Interferon beta-1a
Interferon beta-1a
Rx
Injection
Strength 22 ug/.5mL
NDC 44087-0022-03
Peginterferon beta-1a
Peginterferon beta-1a
Rx
Injection
Strength 125 ug/.5mL
NDC 64406-0011-01

Short-term / As-needed

Related options for acute or bridging use

Acute or bridging use
Dalfampridine
Dalfampridine
Rx
Tablet
Strength 10 mg
NDC 65862-0863-01
Methylprednisolone sodium succinate
Methylprednisolone sodium succinate
Rx
Injection
Strength 40 mg/mL
NDC 00009-0039-28

Situational

Related options for specific presentations

Specific presentations
Baclofen
Baclofen
Rx
Tablet
Strength 20 mg
NDC 72189-0565-60
Natalizumab
Natalizumab
Rx
Injection
Strength 300 mg/15mL
NDC 64406-0008-01
Dantrolene sodium
Dantrolene sodium
Rx
Capsule
Strength 100 mg
NDC 00115-4433-01

Top treatments tried for Multiple Sclerosis

Community-driven data · early preview

Ocrelizumab
1,800 people tried
4.3
Interferon beta-1a
1,520 people tried
4.1
Peginterferon beta-1a
1,240 people tried
4.0
Dalfampridine
960 people tried
3.8
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.